Short answer: THC crosses the placenta and reaches fetal tissue. ACOG, the AAP, and the FDA advise against cannabis use in pregnancy. No safe dose and no safe trimester window has been identified.

read more

How many pregnant women use cannabis

National survey data put past-month cannabis use among pregnant women at 4% to 5%. Rates are higher in women aged 18 to 24. Surveys depend on self-report, so those numbers act as a floor. Urine tests for THC-COOH detect some use that surveys miss.

Cannabis and Pregnant Women: A Safety-First Buying Guide

How THC reaches the fetus

THC is fat-soluble. It crosses the placenta by passive diffusion. In animal models, fetal plasma THC reaches about 10% of the maternal level. THC and its metabolites appear in cord blood, cord tissue, and meconium. Smoke adds carbon monoxide and tar to the exposure. Product potency has changed: NIDA reports THC content in seized cannabis rose from under 4% in 1995 to about 15% in 2018. The same number of puffs now delivers a larger dose.

Cannabis Effects on Pregnancy: What You Need to Know

Birth outcomes tied to exposure

Observational studies link prenatal cannabis exposure to lower birth weight, preterm birth, small-for-gestational-age status, and NICU admission. Most of these studies adjust for tobacco, alcohol, and income. Residual confounding remains. Association in these cohorts is not proof of causation.

health impacts of cannabis on pregnancy

Childhood outcomes

Cohort studies report small differences in attention, impulsivity, and executive function at ages 3 to 6. Findings vary by cohort. Several studies show no effect after adjustment. The case for a causal link is not settled.

CBD in pregnancy

Human data on CBD use during pregnancy are absent. Animal studies show CBD crosses the placenta. The FDA advises against CBD during pregnancy and breastfeeding. CBD products sold online are not all tested for THC content, and some labels understate it. Dose control is a problem because the market is not standardized.

What doctors advise

ACOG recommends that clinicians ask every pregnant patient about cannabis and advise stopping. ACOG does not endorse cannabis for nausea and vomiting of pregnancy. It also opposes legal penalties for use during pregnancy. First-line treatment for nausea includes doxylamine and pyridoxine.

Breastfeeding

THC passes into breast milk. ACOG and the AAP advise against cannabis use while breastfeeding. Milk THC concentrations are low but detectable. Infant exposure tracks maternal dose and timing of use.

Numbers to keep

  • 4% to 5%: past-month use among pregnant women in national surveys
  • Under 4% to about 15%: change in THC potency, 1995 to 2018
  • 0: safe doses of cannabis in pregnancy that have been identified